Rhythm Pharmaceuticals
Rhythm Pharmaceuticals seeks a seasoned Director of Revenue Forecasting and Commercial Performance to analyze and improve the financial performance of its rare disease portfolio in North America. The role involves developing data-driven forecasts, leading strategic planning, and providing actionable insights to support commercial success and business growth.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
96% above the average for this role
Director, Forecasting and Analytics, North America
BeOne Medicines
Senior Manager, Commercial Forecasting
CareDx, Inc.
Director of Commercial Forecasting & Insights
Abbott Laboratories
Associate Director, Commercial Forecasting
ANI Pharmaceuticals
BAI - Forecasting Senior Manager, Rare Disease
Amgen
CD&A - Senior Director, US Forecasting, Rare Disease
Amgen